welcome
Homepage

Homepage

Health

Health

Novo Nordisk accuses telehealth company Hims of 'deceptive marketing' and ends Wegovy partnership

Homepage
Summary
Nutrition label

72% Informative

Hims & Hers Health was accused of deceptively marketing weight-loss drugs.

Novo Nordisk said it took issue with the company’s continued sale of compounded versions of Wegovy .

Heirs & Hers had been offering one-month doses of compounded GLP-1 medications starting at $ 165 per month.

VR Score

69

Informative language

67

Neutral language

36

Article tone

formal

Language

English

Language complexity

51

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links